Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$4,174,016
-$2,475,921 QoQ
Shares Held
3,480
-51.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#1,853
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OPAL CAPITAL LLC holds $50,865,854 across 8 Drug Manufacturers - General names. LLY ranks #5 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
60,314 | $15,317,946 | |
| 2 | ABBV |
AbbVie Inc.
|
47,900 | $12,053,556 | |
| 3 | GSK |
GSK plc
|
108,899 | $5,708,485 | |
| 4 | SNY |
Sanofi
|
125,869 | $5,369,571 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
3,480 | $4,174,016 | |
| 6 | AZN |
Astrazeneca PLC
|
18,998 | $3,602,400 | |
| 7 | MRK |
Merck & Co., Inc.
|
20,497 | $2,633,864 | |
| 8 | NVS |
Novartis AG
|
12,800 | $2,006,016 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,174,016 | 3,480 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $6,649,937 | 7,230 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $702,840 | 654 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||